Aim:The platelet responses to antiplatelet drugs are highly variable.However, the associated mechanisms are poorly defined.The present study aimed to investigate PEAR1 genetic polymorphisms and pharmacogenetic variability in the pharmacodynamics of prasugrel,a new oral antiplatelet agent,in 36 he...Aim:The platelet responses to antiplatelet drugs are highly variable.However, the associated mechanisms are poorly defined.The present study aimed to investigate PEAR1 genetic polymorphisms and pharmacogenetic variability in the pharmacodynamics of prasugrel,a new oral antiplatelet agent,in 36 he...1Vol.3
Abstract Background Platelet Endothelial Aggregation Receptor 1 (PEAR1), a membrane protein highly e...
Platelet response to activation varies widely between individuals but shows interindividual consiste...
<div><p>Platelet aggregation is heritable, and genome-wide association studies have detected strong ...
Aim: The present study aimed to investigate PEAR1 genetic polymorphisms and pharmacogenetic variabil...
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAM...
Platelet aggregation during aspirin treatment displays considerable inter-individual variability. A ...
Background: Platelet aggregation during aspirin treatment displays considerable inter-individual var...
This article is protected by copyright. All rights reserved. The platelet endothelial aggregatio...
Pharmacogenomics is a relatively recent yet rapidly expanding field of study examining how genetic v...
Platelet aggregation is heritable, and genome-wide association studies have detected strong associat...
Background: The role of genetic polymorphisms is important in defining the patient's prognosis and o...
Thienopyridine antiaggregating platelet agents (clopidogrel and prasugrel) act as irreversible P2Y12...
<p>Comparisons of platelet aggregation levels across genotypes were adjusted for the following basel...
Objective: Platelet endothelial aggregation receptor 1 (PEAR1) is a membrane protein involved in pla...
Clopidogrel response varies according to the presence of genetic polymorphisms. The CYP2C19*2 allele...
Abstract Background Platelet Endothelial Aggregation Receptor 1 (PEAR1), a membrane protein highly e...
Platelet response to activation varies widely between individuals but shows interindividual consiste...
<div><p>Platelet aggregation is heritable, and genome-wide association studies have detected strong ...
Aim: The present study aimed to investigate PEAR1 genetic polymorphisms and pharmacogenetic variabil...
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAM...
Platelet aggregation during aspirin treatment displays considerable inter-individual variability. A ...
Background: Platelet aggregation during aspirin treatment displays considerable inter-individual var...
This article is protected by copyright. All rights reserved. The platelet endothelial aggregatio...
Pharmacogenomics is a relatively recent yet rapidly expanding field of study examining how genetic v...
Platelet aggregation is heritable, and genome-wide association studies have detected strong associat...
Background: The role of genetic polymorphisms is important in defining the patient's prognosis and o...
Thienopyridine antiaggregating platelet agents (clopidogrel and prasugrel) act as irreversible P2Y12...
<p>Comparisons of platelet aggregation levels across genotypes were adjusted for the following basel...
Objective: Platelet endothelial aggregation receptor 1 (PEAR1) is a membrane protein involved in pla...
Clopidogrel response varies according to the presence of genetic polymorphisms. The CYP2C19*2 allele...
Abstract Background Platelet Endothelial Aggregation Receptor 1 (PEAR1), a membrane protein highly e...
Platelet response to activation varies widely between individuals but shows interindividual consiste...
<div><p>Platelet aggregation is heritable, and genome-wide association studies have detected strong ...